Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer

被引：0
|
作者：
Sun, W. [1 ]
Ma, K. [1 ]
Wang, X. [1 ]
Liu, Y. [1 ]
He, H. [1 ]
Guo, Y. [1 ]
机构：
[1] Jinlin Univ, Hosp 1, Changchun, Jilin, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Programmed death-ligand 1; neo-adjuvant chemotherapy; lung cancer;
D O I：
10.1016/j.jtho.2017.09.303
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-006
引用
收藏
页码：S1996 / S1996
页数：1
相关论文
共 50 条
  • [21] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [22] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [23] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
    Maureen L. Drakes
    Swati Mehrotra
    Monica Aldulescu
    Ronald K. Potkul
    Yueying Liu
    Anne Grisoli
    Cara Joyce
    Timothy E. O’Brien
    M. Sharon Stack
    Patrick J. Stiff
    Journal of Ovarian Research, 11
  • [24] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand-1 (PD-L1) in ovarian cancer
    Drakes, Maureen L.
    Mehrotra, Swati
    Aldulescu, Monica
    Potkul, Ronald K.
    Liu, Yueying
    Grisoli, Anne
    Joyce, Cara
    O'Brien, Timothy E.
    Stack, M. Sharon
    Stiff, Patrick J.
    JOURNAL OF OVARIAN RESEARCH, 2018, 11
  • [25] Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1)
    Wen, Biyan
    Zhao, Lin
    Wang, Yuchu
    Qiu, Chuangnan
    Xu, Zhimin
    Huang, Kunling
    Zhu, He
    Li, Zemin
    Li, Huangjin
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2020, 50 (03): : 252 - 259
  • [26] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE GRADE 3 ENDOMETRIOID ADENOCANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Guzel, A. B.
    Khatib, G.
    Seydaoglu, G.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1126 - 1126
  • [27] Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar R. Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2016, 128 : 183 - 183
  • [28] Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
    Zak, Krzysztof M.
    Kitel, Radoslaw
    Przetocka, Sara
    Golik, Przemyslaw
    Guzik, Katarzyna
    Musielak, Bogdan
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    STRUCTURE, 2015, 23 (12) : 2341 - 2348
  • [29] Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers
    Guan, Jian
    Lim, Khin Sandar
    Mekhail, Tarek
    Chang, Chung-Che
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (06) : 851 - 861
  • [30] Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms
    Chen, Chi
    Pandey, Anita
    Kundra, Ajay
    Kodali, Sreenath
    Wong, Ching
    Cheung, Tony W.
    Gotlieb, Vladimir K.
    Joseph, Gardith
    Tribie, Sophia
    Wang, Jen-Chin
    BLOOD, 2018, 132
12345